Method for loading hydrophobic drug by using DNA hydrogel
By modifying cholesterol on DNA hydrogels to form hydrophobic DNA hydrogels, the problem of hydrophobicity limitation of DNA molecules is solved, the efficient loading and biocompatibility of hydrophobic drugs is achieved, and new drug delivery ideas are provided.
Patent Information
- Application Number
- CN202411169140.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-26
AI Technical Summary
The hydrophobicity of DNA molecules limits its use in hydrophobic drugs, resulting in poor drug delivery.
DNA hydrogel was constructed by rolling ring amplification method, and single strands of DNA modified with cholesterol at both ends were added thereon to form a hydrophobic DNA hydrogel, which used cholesterol to provide a hydrophobic environment to load hydrophobic drugs.
It improves the hydrophobic properties of DNA hydrogels, achieves efficient loading of a variety of hydrophobic drugs, enhances the biocompatibility and therapeutic effects of drugs, and has a simple synthesis process.
Smart Images

Figure CN119015444A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of drug delivery, and more particularly to a method for loading hydrophobic drugs using DNA hydrogel. Background Art
[0002] The clinical use of drugs is often limited by their strong hydrophobicity, low stability and high toxic side effects. Drug delivery systems (DDS) can effectively encapsulate and protect drugs, improve their biocompatibility, specificity of action and therapeutic effects. DNA hydrogels are three-dimensional network structures. Compared with synthetic polymers, DNA biopolymers can manipulate specific sites of DNA through enzymes to form different shapes, or respond specifically to specific diseases; at the same time, other functional materials such as new carbon materials, biomolecules, synthetic organic molecules and metal nanoparticles can be introduced into DNA hydrogels, making the design of DNA hydrogels more diverse; and its excellent solubility, biocompatibility, biodegradability and other advantages, especially its "sponge-like" porous structure, make DNA hydrogels a good drug carrier. However, the hydrophobicity of DNA molecules limits its application in hydrophobic drugs. Summary of the invention
[0003] The purpose of the present invention is to provide a method for loading hydrophobic drugs using DNA hydrogel, thereby solving the problem in the prior art that the hydrophobicity of DNA molecules limits their application in hydrophobic drugs.
[0004] In order to solve the above problems, the present invention adopts the following technical solutions:
[0005] Provided is a method for loading hydrophobic drugs using DNA hydrogel, comprising the following steps: S1: constructing a DNA hydrogel using a rolling circle amplification method; S2: adding a single DNA strand modified with cholesterol at both ends to the DNA hydrogel, wherein the single DNA strand and the long DNA strand amplified in step S1 are subjected to base complementary pairing to obtain a hydrophobic DNA hydrogel; S3: adding a hydrophobic drug to the hydrophobic DNA hydrogel, wherein the hydrophobic drug is loaded into a hydrophobic cavity formed by cholesterol, and the loaded DNA hydrogel is stored at 4°C.
[0006] Preferably, step S1 comprises: mixing the RCA template, primers, dNTPs and DNA polymerase to form an amplification system, amplifying for 2 to 20 hours and then quenching at 65° C. for 10 minutes to form a DNA hydrogel.
[0007] Preferably, in step S1, the amplification time used is 18 to 20 hours, and the prepared DNA hydrogel has high stability.
[0008] Preferably, in step 2), the number of bases in the DNA single strand modified with cholesterol at both ends can be adjusted, and the hydrophobic properties of the hydrophobic DNA hydrogel can be adjusted by adjusting the number of bases in the DNA single strand.
[0009] Preferably, in step 2), the number of bases in the single-stranded DNA modified with cholesterol at both ends is adjusted so that four single-stranded DNA modified with cholesterol at both ends are connected to each long DNA chain.
[0010] Preferably, four segments of 15-base cholesterol-DNA are used, with one cholesterol modified at the 5' end and the 3' end of each segment. It should be understood that this DNA is only used as an example of a preferred embodiment and is not intended to be limiting.
[0011] Preferably, in step 3), before being added to the hydrophobic DNA hydrogel, the hydrophobic drug needs to be solubilized with the aid of an organic reagent DMSO.
[0012] Preferably, in step 3), the hydrophobic drug includes: dexamethasone, DOX, or lutein.
[0013] According to the method provided by the present invention, the amplification template of the DNA hydrogel has no sequence restriction, the amount of cholesterol in the cholesterol-DNA has no restriction, and the selection of the hydrophobic drug is not restricted by structure.
[0014] It should be understood that rolling circle amplification (RCA) is a constant temperature nucleic acid amplification method developed in recent years. According to a method for constructing a hydrophobic DNA hydrogel provided by the present invention, its working principle is as follows Figure 1 As shown, first, a DNA hydrogel is constructed using a rolling circle amplification method. The specific method is: use T4 ligase to connect the linear template chain into a circular template through primers, add dNTP and phi29 polymerase for amplification, amplify to obtain a long DNA chain, and obtain a DNA hydrogel; then, add cholesterol-DNA to connect it to the amplified long DNA chain through base complementary pairing to form a hydrophobic DNA hydrogel; then, add a hydrophobic drug to the hydrophobic DNA hydrogel, and the hydrophobic drug is loaded by the hydrophobic cavity formed by cholesterol, thereby successfully realizing the loading of the hydrophobic drug by the DNA hydrogel.
[0015] The key invention of the present invention is that a DNA hydrogel is constructed by a rolling circle amplification method, and cholesterol-modified DNA is inserted into the DNA hydrogel through base complementarity. Cholesterol, as a hydrophobic molecule, provides a hydrophobic environment in the hydrogel, providing conditions for the loading of hydrophobic drugs.
[0016] The present invention uses cholesterol to modify DNA hydrogel for the first time. By introducing the hydrophobic group cholesterol into the DNA hydrogel, its internal hydrophobicity can be enhanced to achieve the purpose of loading drugs, providing a new idea for the application of DNA in hydrophobic drugs. The method provided by the present invention can greatly improve the hydrophobic properties of DNA hydrogel. The method is not limited to DNA sequence and can be applied to all DNA hydrogels. It can also load a variety of hydrophobic drugs, and the synthesis process is simple, so it has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 A schematic diagram of a method for synthesizing a hydrophobic DNA hydrogel provided by the present invention;
[0018] Figure 2 The SEM images of the DNA hydrogel in Example 1, the upper one is the DNA hydrogel without cholesterol, and the structure of the DNA hydrogel can be seen, and the lower one is the hydrophobic DNA hydrogel containing cholesterol;
[0019] Figure 3 The rheological curves of the two hydrogels measured by a rheometer in Example 1, the left side is the rheological data of the DNA hydrogel, and the right side is the rheological data of the hydrophobic DNA hydrogel;
[0020] Figure 4 This is the drug loading condition of the DNA hydrogel in Example 2. DETAILED DESCRIPTION
[0021] The present invention is further described below in conjunction with specific examples. It should be understood that the following examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples that do not specify specific conditions are selected according to conventional methods and conditions, or according to the product specifications.
[0022] Example 1 Synthesis of hydrophobic DNA hydrogel
[0023] The RCA template (0.1 μM), primers, dNTPs and phi29 DNA polymerase were mixed to form a 100 μL amplification system. After 20 hours of amplification, the system was quenched at 65°C for 10 minutes to form a DNA hydrogel. Different proportions of 5 μM cholesterol-DNA (25 μL, 50 μL) were added to the DNA hydrogel, annealed and hybridized to form a hydrophobic DNA hydrogel. Part of the water was evaporated to form a 100 μL system. The formed DNA hydrogel and hydrophobic DNA hydrogel were characterized by SEM and rheology respectively. The characterization results are shown in the figure. Figure 2-Figure 3 shown.
[0024] like Figure 2As shown in the figure, the hydrogel has no obvious structural changes after adding cholesterol, indicating that the addition of cholesterol does not affect the morphology of the DNA hydrogel itself. Figure 3 As shown, the addition of cholesterol did not significantly change the rheological properties of DNA hydrogels.
[0025] The DNA sequences (SEQ ID No. 1-6) used in this example are shown in Table 1 below.
[0026] Table 1
[0027] Example 2 Hydrophobic DNA hydrogel loaded with dexamethasone
[0028] 200 μg of dexamethasone was added to the hydrophobic DNA hydrogel and oscillated at room temperature for 4 h. The hydrogel was separated from the reaction system. The mass of the remaining dexamethasone in the reaction system was detected by ultraviolet spectrometer, and the dexamethasone loading in the hydrogel was obtained by subtraction.
[0029] The results are as follows Figure 4 As shown, with the increase of cholesterol-DNA addition, the loading capacity of DNA hydrogel for hydrophobic drugs gradually increased.
[0030] The above is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention. The above embodiments of the present invention can also be modified in various ways. All simple, equivalent changes and modifications made according to the claims and the description of the present invention fall within the scope of protection of the claims of the present invention. The contents not described in detail in the present invention are all conventional technical contents.
Claims
1. A method for loading hydrophobic drugs using DNA hydrogels, It is characterized in that The following steps are involved: S1: Construction of DNA hydrogel using rolling circle amplification method; S2: adding a single DNA strand modified with cholesterol at both ends to the DNA hydrogel, wherein the single DNA strand and the long DNA strand amplified in step S1 undergo base complementary pairing to obtain a hydrophobic DNA hydrogel; S3: adding a hydrophobic drug into the hydrophobic DNA hydrogel, wherein the hydrophobic drug is loaded into the hydrophobic cavity formed by cholesterol, and the drug-loaded DNA hydrogel is stored at 4°C.
2. The method according to claim 1, It is characterized in that Step S1 includes: mixing the RCA template, primers, dNTPs and DNA polymerase to form an amplification system, amplifying for 2 to 20 hours and then quenching at 65° C. for 10 minutes to form a DNA hydrogel.
3. The method according to claim 1, It is characterized in that In step S1, the amplification time adopted is 18 to 20 hours, and the prepared DNA hydrogel has high stability.
4. The method according to claim 1, It is characterized in that In step 2), the number of bases in the DNA single strand modified with cholesterol at both ends can be adjusted, and the hydrophobic properties of the hydrophobic DNA hydrogel can be adjusted by adjusting the number of bases in the DNA single strand.
5. The method according to claim 1, It is characterized in that In step 2), the number of bases in the single-stranded DNA modified with cholesterol at both ends is adjusted so that four single-stranded DNA modified with cholesterol at both ends are connected to each long DNA chain.
6. The method according to claim 1, It is characterized in that In step 3), before being added to the hydrophobic DNA hydrogel, the hydrophobic drug needs to be solubilized with the aid of an organic reagent, DMSO.
7. The method according to claim 1, It is characterized in that In step 3), the hydrophobic drug includes: dexamethasone, DOX, or lutein.
